Cormorant Asset Management, LP Pyxis Oncology, Inc. Transaction History

Cormorant Asset Management, LP

  • $1.43 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
SELL
$1.38 - $6.0 $546,917 - $2.38 Million
-396,317 Reduced 59.25%
272,537 $1.09 Million
Q4 2022

Feb 14, 2023
SELL
$1.14 - $2.0 $1 - $2
-1 Reduced -0.0%
668,854 $896,000
Q3 2022

Nov 14, 2022
BUY
$1.88 - $3.03 $1 - $3
1 Added 0.0%
668,855 $1.32 Million
Q4 2021

Feb 14, 2022
BUY
$8.39 - $13.64 $5.61 Million - $9.12 Million
668,854 New
668,854 $7.12 Million

Others Institutions Holding PYXS

# of Institutions
101
Shares Held
28.2M
Call Options Held
539K
Put Options Held
54.1K
View Full List

About Pyxis Oncology, Inc.

PYXS Quotes by TradingView
  • Ticker PYXS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,096,400
  • Market Cap $59.3M
  • Description
  • Pyxis Oncology, Inc., a preclinical stage biopharmaceutical company, engages in the development of therapies to treat cancers. Its immune-oncology product candidates include PYX-106, an investigational fully human immunoglobulin G1 isotype siglec-15 targeting antibody for the treatment of thyroid cancer, head and neck squamous cell carcinoma, no...
More about PYXS
Track This Portfolio

Track Cormorant Asset Management, LP Portfolio

Follow Cormorant Asset Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cormorant Asset Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Cormorant Asset Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email